Trump’s health secretary has halted federal flu vaccine promotions, citing personal beliefs about vaccine risks.
Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...
Moderna's mRNA-1010 flu vaccine for older adults could be made available by the end of 2026, the pharmaceutical company ...
Flu kills five more children in a week as doctors brace for influenza surge across nation - Around 90 percent of child flu ...
With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
The company revised its plan to seek full approval for middle-aged adults and accelerated approval for seniors.
February 21, 2026 - Next generation influenza vaccines that provide broader and longer-lasting protection than existing seasonal vaccines, could play a vital role in reducing the global burden of ...
The number of people getting sick with influenza B has gone up for three weeks straight, now making up about a third of flu ...
The latest data released Friday by the Montana Department of Public Health and Human Services shows an uptick in influenza ...
The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA ...
The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results